PGNY 15.44 Stock Price Progyny, Inc.
Range: | 13.39-42.08 | Vol Avg: | 2277165 | Last Div: | 0 | Changes: | 0.47 |
Beta: | 1.44 | Cap: | 1.31B | Currency: | USD | Exchange: | NASDAQ |
Sector: | Healthcare | IPO: | Fri Oct 25 2019 | Empoloyees: | 563 |
CUSIP: | 74340E103 | CIK: | 0001551306 | ISIN: | US74340E1038 | Country: | US |
CEO: | Mr. David J. Schlanger J.D. | Website: | https://www.progyny.com |
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.